Sarah Jackson PhD, MPH

Sarah Jackson, Ph.D., M.P.H., joined DCEG as a postdoctoral fellow in the Infections and Immunoepidemiology Branch (IIB) in 2018 and was inducted into the NIH Independent Research Scholar Program and promoted to research fellow in 2021. She was selected as an Earl Stadtman tenure-track investigator and an NIH Distinguished Scholar in 2023. Dr. Jackson earned an M.P.H. in epidemiology in 2008 from the George Washington University, Washington, D.C., and a Ph.D. in epidemiology in 2018 from the University of Maryland, Baltimore.

Dr. Jackson has received numerous awards for her work, including the Sallie Rosen Kaplan Fellowship for Women Scientists in Cancer Research, NIH Fellows Award for Research Excellence, the NCI Director’s Intramural Innovation Award, William G. Coleman Jr. Ph.D., Minority Health and Health Disparities Research Innovation Award, and the DCEG Intramural Research Award.

Dr. Jackson’s research seeks to understand the mechanisms by which sex differences impact cancer risk and outcomes. Specifically, her research addresses how sex differences (hormones, chromosomes, etc.) influence cancer risk and survival.